INVIVO THERAPEUTICS HOLDINGS CORP. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Invivo Therapeutics Holdings Corp. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2023.
  • Invivo Therapeutics Holdings Corp. Common Stock, Shares, Outstanding for the quarter ending September 30, 2023 was 3.11M shares, a 123% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 3.11M +1.71M +123% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 3.11M +1.71M +123% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 3.11M +1.73M +127% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 2.43M +1.06M +77.3% Dec 31, 2022 10-Q 2023-11-08
Q3 2022 1.39M -32.9M -95.9% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 1.39M -32.9M -95.9% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 1.37M -32.9M -96% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 1.37M -22.3M -94.2% Dec 31, 2021 10-K 2023-03-01
Q3 2021 34.3M +29.4M +602% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 34.3M +29.4M +602% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 34.3M +31.7M +1232% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 23.6M +23.1M +4191% Dec 31, 2020 10-K 2022-03-07
Q3 2020 4.88M -4.64M -48.7% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 4.88M -4.43M -47.6% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 2.57M -6.74M -72.4% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 551K +240K +77.5% Dec 31, 2019 10-K 2021-03-01
Q3 2019 9.52M +1.01M +11.9% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 9.31M +5.23M +128% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 9.31M +7.75M +496% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 310K -1.06M -77.4% Dec 31, 2018 10-K 2020-02-20
Q3 2018 8.51M -25.7M -75.2% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 4.08M -28.1M -87.3% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 1.56M -30.6M -95.1% Mar 31, 2018 10-Q 2018-05-07
Q4 2017 1.37M -30.7M -95.7% Dec 31, 2017 10-K 2019-04-01
Q3 2017 34.2M +2.2M +6.87% Sep 30, 2017 10-Q 2017-10-30
Q2 2017 32.2M +258K +0.81% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 32.1M +218K +0.68% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 32M +4.49M +16.3% Dec 31, 2016 10-K 2018-03-12
Q3 2016 32M +6.02M +23.1% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 31.9M +5.91M +22.7% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 31.9M +5.89M +22.7% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 27.6M +4.1M +17.5% Dec 31, 2015 10-K 2017-03-10
Q3 2015 26M -67.5M -72.2% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 26M -67.4M -72.2% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 26M -53M -67.1% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 23.5M -55.3M -70.2% Dec 31, 2014 10-K 2016-03-04
Q3 2014 93.5M +14.8M +18.8% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 93.4M +15.1M +19.2% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 79M +12.8M +19.4% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 78.8M +12.9M +19.6% Dec 31, 2013 10-K 2015-03-11
Q3 2013 78.7M +13.1M +20% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 78.4M +13.7M +21.1% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 66.2M +2.26M +3.54% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 65.9M +12.1M +22.5% Dec 31, 2012 10-K 2014-03-17
Q3 2012 65.6M +13.6M +26.2% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 64.7M +13M +25% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 63.9M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 53.8M +2.11M +4.09% Dec 31, 2011 10-K 2013-03-12
Q3 2011 52M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 51.7M Jun 30, 2011 10-Q 2011-08-10
Q4 2010 51.6M Dec 31, 2010 10-K 2012-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.